PhaseBio Pharmaceuticals, Inc. PHAS NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

Il y a eu 50 transactions d'initiés récentes enregistrées pour PhaseBio Pharmaceuticals, Inc. (PHAS), dont 35 achats et 13 ventes. Le total des achats d'initiés s'élève à $1.07M et le total des ventes d'initiés à $421.77K.

Les initiés notables ayant une activité récente comprennent Harrigan Edmund, Loewy Caroline M, Hutson Nancy J. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.

Transactions d'Initiés — PHAS

Date	Nom	Rôle	Type de Transaction	Actions	Prix Moyen	Valeur	Actions détenues
2023-05-19	Harrigan Edmund	Director	Exercice d'Options	3,750	-	-	-
2023-05-19	Loewy Caroline M	Director	Exercice d'Options (Vente)	3,750	-	-	-
2023-05-19	Hutson Nancy J	Director	Exercice d'Options (Vente)	3,750	-	-	-
2023-05-19	Van Den Broek Richard	Director	Exercice d'Options (Vente)	3,750	-	-	-
2023-05-19	Thorp Clay	Director	Exercice d'Options	3,750	-	-	-
2023-05-19	Humphries William D.	Director	Exercice d'Options (Vente)	2,538	-	-	-
2023-05-19	Sapir Alex	Director	Exercice d'Options (Vente)	3,750	-	-	-
2022-10-25	New Enterprise Associates 13 Lp	Director	Vente Informative	1,784,109	$0.15	$262.26K	4,857,525
2022-05-20	Mow Jonathan P	Chief Executive Officer	Attribution de RSU	10,918	$0.68	$7.44K	132,502
2022-05-20	Sharp John P	Chief Financial Officer	Attribution de RSU	6,026	$0.68	$4.11K	65,767
2022-05-20	Arnold Susan Elizabeth	SVP, Technical Operations	Attribution de RSU	10,917	$0.68	$7.44K	41,236
2022-05-20	Hanson Kristopher	SVP and General Counsel	Attribution de RSU	4,831	$0.68	$3.29K	8,463
2022-05-20	Burkhardt Glen	SVP of Human Resources	Vente Informative	11,248	$0.79	$8.89K	-
2022-05-20	Birchall Jonathan	Chief Commercial Officer	Attribution de RSU	20,000	$0.68	$13.63K	20,000
2022-05-19	Harrigan Edmund	Director	Attribution de RSU	3,750	-	-	3,750
2022-05-19	Loewy Caroline M	Director	Attribution de RSU	3,750	-	-	3,750
2022-05-19	Hutson Nancy J	Director	Attribution de RSU	3,750	-	-	3,750
2022-05-19	Van Den Broek Richard	Director	Attribution de RSU	3,750	-	-	3,750
2022-05-19	Thorp Clay	Director	Attribution de RSU	3,750	-	-	3,750
2022-05-19	Humphries William D.	Director	Attribution de RSU	3,750	-	-	3,750
2022-05-19	Sapir Alex	Director	Attribution de RSU	3,750	-	-	3,750
2022-05-19	Humphries William D.	Director	Attribution de RSU	2,538	-	-	2,538
2022-02-24	Mow Jonathan P	Chief Executive Officer	Attribution de RSU	82,500	-	-	82,500
2022-02-24	Sharp John P	Chief Financial Officer	Attribution de RSU	24,750	-	-	24,750
2022-02-24	Lee John Sang	Chief Medical Officer	Attribution de RSU	24,750	-	-	24,750
2022-02-24	Arnold Susan Elizabeth	SVP, Technical Operations	Attribution de RSU	18,750	-	-	18,750
2022-02-24	Hanson Kristopher	VP, Head of Legal	Attribution de RSU	18,750	-	-	18,750
2022-02-24	Burkhardt Glen	VP, Human Resources	Attribution de RSU	18,750	-	-	18,750
2022-02-24	Birchall Jonathan	Chief Commercial Officer	Attribution de RSU	11,250	-	-	11,250
2021-11-19	Mow Jonathan P	Chief Executive Officer	Attribution de RSU	5,623	$2.01	$11.3K	172,473
2021-11-19	Sharp John P	Chief Financial Officer	Attribution de RSU	2,017	$2.01	$4.05K	59,741
2021-11-19	Arnold Susan Elizabeth	SVP, Technical Operations	Attribution de RSU	2,559	$2.01	$5.14K	30,319
2021-11-19	Hanson Kristopher	VP, Head of Legal	Attribution de RSU	1,545	$2.01	$3.11K	3,632
2021-11-19	Burkhardt Glen	VP, Human Resources	Vente Informative	5,766	$2.37	$13.67K	-
2021-11-08	Hutson Nancy J	Director	Exercice d'Options (Vente)	7,400	$3.15	$23.31K	-
2021-11-08	Birchall Jonathan	Officer	Inconnu	-	-	-	-
2021-11-08	Birchall Jonathan	Chief Commercial Officer	Attribution de RSU	250,000	$3.37	$842.5K	250,000
2021-11-05	Hutson Nancy J	Director	Exercice d'Options (Vente)	24,860	$2.26	$56.18K	2,256
2021-11-03	Mow Jonathan P	Chief Executive Officer	Exercice d'Options (Vente)	20,000	$1.24	$24.8K	108,767
2021-11-03	Sharp John P	Chief Financial Officer	Exercice d'Options	7,500	$1.68	$12.6K	57,724
2021-09-14	Humphries William D.	Director	Inconnu	-	-	-	-
2021-09-14	Humphries William D.	Director	Attribution de RSU	28,000	$2.80	$78.4K	28,000
2021-08-27	Mow Jonathan P	Chief Executive Officer	Exercice d'Options (Vente)	20,000	$1.24	$24.8K	128,767
2021-08-18	Thorp Clay	Director	Achat Informatif	10,000	$3.00	$30K	32,943
2021-08-18	Hutson Nancy J	Director	Achat Informatif	3,000	$3.08	$9.24K	4,000
2021-08-18	Hutson Nancy J	Director	Achat Informatif	3,000	$3.08	$9.24K	4,000
2021-08-03	Sharp John P	Chief Financial Officer	Attribution de RSU	7,500	$1.68	$12.6K	50,224
2021-08-03	Sharp John P	Chief Financial Officer	Exercice d'Options	7,500	$1.68	$12.6K	50,224
2021-07-12	Arnold Susan Elizabeth	VP, Preclinical and Chem	Exercice d'Options (Vente)	4,519	$1.74	$7.86K	-
2021-07-12	Arnold Susan Elizabeth	VP, Preclinical and Chem	Attribution de RSU	4,519	$1.74	$7.86K	27,760

■ Informatif — transaction sur marché ouvert (la plus significative) ■ Non informatif (achat) — récompense, exercice d'option, conversion ■ Non informatif (vente) — retenue fiscale, vente à l'acquisition ■ Neutre — don, fiducie, expiration